Scope and aim
Pharmacogenetics and pharmacogenomics (PGX) are emerging disciplines that focus on genetic determinants of drug response at the levels of single genes or the entire human genome, respectively. The network is the voice of the European science community in pharmacogenetics and pharmacogenomics, with the following objectives. The Network provides a platform for experts for gathering and disseminating knowledge, determining PGX-strategies; for collaboration between academic institutions and industry; for mechanisms of set up and exchange of databases; and for gatherings and promotion of knowledge about pharmacogenetics and genomics in Europe. Objectives also include to serve as a knowledge-bank for EU research programme calls, and to engage in education and training, particularly, PHD students.
Anke-Hilse Maitland-van der Zee